Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118573303 | 11857330 | 3 | F | 20151206 | 20160915 | 20151221 | 20160916 | EXP | US-TAKEDA-2015MPI008541 | TAKEDA | 79.12 | YR | F | Y | 61.68000 | KG | 20160916 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118573303 | 11857330 | 1 | PS | Ixazomib | IXAZOMIB | 1 | Oral | 4 MG, UNK | D | 208462 | 4 | MG | CAPSULE | ||||||
| 118573303 | 11857330 | 2 | SS | Lenalidomide | LENALIDOMIDE | 1 | Oral | 10 MG, UNK | D | 0 | 10 | MG | CAPSULE | ||||||
| 118573303 | 11857330 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 5 MG, UNK | D | 0 | 5 | MG | TABLET | ||||||
| 118573303 | 11857330 | 4 | C | TRIMETHOPRIM. | TRIMETHOPRIM | 1 | Ophthalmic | D | 0 | ||||||||||
| 118573303 | 11857330 | 5 | C | POLYMYXIN | POLYMYXIN | 1 | Ophthalmic | D | 0 | ||||||||||
| 118573303 | 11857330 | 6 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Oral | 40 MG, QD | D | 0 | 40 | MG | TABLET | QD | |||||
| 118573303 | 11857330 | 7 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | D | 0 | TABLET | ||||||||||
| 118573303 | 11857330 | 8 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, QD | D | 0 | 40 | MG | TABLET | QD | |||||
| 118573303 | 11857330 | 9 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 4 MG, 1/WEEK | D | 0 | 4 | MG | TABLET | /wk | |||||
| 118573303 | 11857330 | 10 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 10 MG, UNK | D | 0 | 10 | MG | TABLET | ||||||
| 118573303 | 11857330 | 11 | C | ASPIRIN 81 | ASPIRIN | 1 | Oral | 81 MG, QD | D | 0 | 81 | MG | TABLET | QD | |||||
| 118573303 | 11857330 | 12 | C | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | Oral | 400 MG, QD | D | 0 | 400 | MG | TABLET | QD | |||||
| 118573303 | 11857330 | 13 | C | SENNOSIDES A+B | SENNOSIDES A AND B | 1 | Oral | 8.6 MG, UNK | D | 0 | 8.6 | MG | TABLET | ||||||
| 118573303 | 11857330 | 14 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | Oral | 50 MG, UNK | D | 0 | 50 | MG | TABLET | ||||||
| 118573303 | 11857330 | 15 | C | POLYETHYLENE GLYCOL 3350. | POLYETHYLENE GLYCOL 3350 | 1 | Oral | 17 UNK, UNK | D | 0 | POWDER (EXCEPT [DPO]) | ||||||||
| 118573303 | 11857330 | 16 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 70 MG, UNK | D | 0 | 70 | MG | TABLET | ||||||
| 118573303 | 11857330 | 17 | C | DICYCLOMINE /00068601/ | DICYCLOMINE HYDROCHLORIDE | 1 | Oral | 20 MG, UNK | D | 0 | 20 | MG | TABLET | ||||||
| 118573303 | 11857330 | 18 | C | DETROL | TOLTERODINE TARTRATE | 1 | Oral | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118573303 | 11857330 | 1 | Plasma cell myeloma |
| 118573303 | 11857330 | 2 | Plasma cell myeloma |
| 118573303 | 11857330 | 3 | Plasma cell myeloma |
| 118573303 | 11857330 | 6 | Depression |
| 118573303 | 11857330 | 7 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118573303 | 11857330 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118573303 | 11857330 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118573303 | 11857330 | 1 | 20150331 | 20151203 | 0 | |
| 118573303 | 11857330 | 2 | 20150331 | 20151202 | 0 | |
| 118573303 | 11857330 | 3 | 20150331 | 20151203 | 0 |